Eucalyptus (1,8-Cineole).
Eucalyptus oil compound for sinus and lung congestion The main compound in rectified eucalyptus oil. In a capsule it supports comfortable breathing and that clear, open feeling through the nose and chest.
Reviewed March 2026
- Category
- Herb
- Also filed under
- SinusitisBronchitisDecongestant
What Eucalyptus (1,8-Cineole) is, and what it does.
- Does it work
- Suits people who want breathing comfort through pollen season or a dry indoor winter. A cineole-rectified capsule gives you a known amount rather than a guess from crude oil.
- How much to take
- Start with 200 to 600mg a day of a cineole-rectified capsule. That band is where daily breathing comfort sits, and the 1,200mg used in trials is a research condition.
- Time to feel it
- The cooling feeling in the nose and throat arrives within an hour of an oral dose, because the molecule is volatile and comes back out in your breath.
- The first dose
- Within an hour you get the cool, open feeling through the nose and throat, and you taste it on your breath. Take it with food if it repeats on you.
- With regular use
- Used across a season it keeps supporting comfortable breathing. Nobody has measured what months of continuous oral use does.
- How well tolerated
- Not for infants or young children, and undiluted oil should never be swallowed. Cineole affects liver enzymes, so check first if you're pregnant or taking medication.
- How it feels
- Cool and sharp. You feel it in the nose and throat within minutes and taste it on your breath, which is the volatility rather than any change in tissue temperature.
- The overlooked benefit
- The cooling comes from switching on TRPM8, the same cold-sensing channel menthol hits, so your nose feels more open with no actual temperature change at all.
200 to 600mg a day is where Eucalyptus (1,8-Cineole) works.
Source: Worth et al., Respir Med, 2009; Fischer & Dethlefsen, Clin Investig, 2013
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Eucalyptus (1,8-Cineole) has emerging evidence. Based on 10+ studies.
- comfortable breathing and clear sinusesRandomised trial
- cooling sensation in the nose and throatNarrative review
- antimicrobial activity in laboratory cultureIn vitro study
- induction of hepatic cytochrome P450 enzymesAnimal study
Questions people ask about Eucalyptus (1,8-Cineole).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Menthol acts on TRPM8 cold receptors to give a sensation of easier airflow while cineole works as a secretolytic that thins mucus. Respiratory preparations have combined the two for well over a century because the actions do not overlap.
Thymol and carvacrol relax bronchial smooth muscle and act on airway secretions, while cineole is a secretolytic that changes mucus rheology. European monograph-style cough blends pair them for that reason.
Ivy saponins act on beta-2 adrenergic signalling in airway cells to raise surfactant output, while cineole thins existing mucus. Combination products use both because they meet at the same secretion but by different routes.
NAC breaks the disulfide bridges that make mucin viscous, a direct chemical mucolysis, while cineole acts on the secretory cells themselves. The two lower mucus viscosity by unrelated mechanisms.
Mullein mucilage coats and soothes irritated airway lining while cineole works on secretion viscosity underneath. Traditional respiratory teas combine a demulcent with a volatile oil for that pairing of surfaces.
Marshmallow polysaccharides form a soothing film over the throat, a purely physical action, while cineole is absorbed and acts on airway secretion. The formulation logic is one local and one systemic layer.
Glycyrrhizin acts as a demulcent and mild expectorant on the upper airway, complementing the secretolytic action of cineole lower down. The two appear together across long-established cough formulas.
Elecampane sesquiterpene lactones and inulin are used as expectorants alongside volatile oils such as cineole. Each acts on a different part of mucus handling in traditional practice.
Carvacrol and cineole are both lipophilic monoterpenes that partition into microbial membranes, and cineole additionally acts as a permeation enhancer for other terpenes. Blends use them together for that membrane effect.
Plantain mucilage and aucubin soothe irritated airway lining while cineole works on secretion consistency. Traditional cough syrups pair the soothing layer with the volatile one.
Rosemary essential oil carries 1,8-cineole as one of its major constituents alongside camphor and alpha-pinene, so combining the two raises total cineole exposure from a single class of compound. Formulators should count the cineole contribution from both rather than from the eucalyptus alone. The chemistry is settled; the combined effect is not separately characterised.
Ginger appears alongside aromatic oils in traditional preparations aimed at comfort and warmth. Gingerols act on TRPV1 while cineole acts at TRPM8, so the sensory effects are separate rather than shared. The pairing is customary rather than tested.
Propolis resin and eucalyptus oil are combined in sprays and lozenges, each contributing its own chemistry: flavonoids and phenolic acids from the resin, a volatile monoterpene oxide from the oil. Both have been examined separately in laboratory antimicrobial work. No combination study establishes an interaction.
Ascorbate is a routine component of seasonal formulas that also carry aromatic oils, contributing an established role in normal immune function. It does not interact chemically with cineole. The combination is product design plus a settled nutrient role.
Zinc is required by numerous enzymes and transcription factors involved in normal immune cell function, an established nutritional role independent of any botanical. Lozenges and sprays combine it with aromatic oils for the sensory and the nutritional contribution respectively. The two act by unrelated routes.
N-acetylcysteine reduces the disulfide bridges that crosslink mucin glycoproteins, lowering the viscosity of secretions, while cineole is described as acting on secretion volume and ciliary movement. The two approaches to normal airway clearance are chemically distinct. Combination outcome data is not established.
Quercetin appears in the same seasonal formulas as aromatic oils, contributing flavonol chemistry studied in laboratory models of mast cell signalling. Its poor water solubility makes it a formulation challenge in liquids that also carry volatile oils. The pairing is product convention.
Bromelain is a proteolytic enzyme complex from pineapple stem used in formulas aimed at normal sinus comfort, often alongside aromatic oils. Their mechanisms do not overlap: one is enzymatic, the other volatile and sensory. Enteric coating is usually needed for the enzyme, which constrains how the two can be combined in one dose form.
Melissa leaf contributes citral and citronellal to a blend where eucalyptus contributes cineole, giving different volatile profiles from the same plant family group. Both appear in traditional infusions and steam preparations. There is no established mechanistic interaction between the two oils.
Elderberry contributes anthocyanins in a sweet syrup base that carries a small quantity of aromatic oil well. The two are combined for complementary sensory and traditional-use reasons rather than for any shared target. No combination study addresses them together.
1,8-cineole is metabolised by hepatic cytochrome P450 enzymes and has been shown in animal work to induce several of them, while silymarin is described as inhibiting certain P450 isoforms in laboratory systems. Taken together the two push liver enzyme activity in opposing directions. Anyone taking a medicine metabolised by these enzymes should regard this as a reason to space or check.
Nothing specific on file for Eucalyptus (1,8-Cineole). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Eucalyptus (1,8-Cineole) actually does.
1,8-cineole, also called eucalyptol, is a bicyclic monoterpene ether and is the dominant constituent of rectified Eucalyptus globulus leaf oil, typically making up the large majority of the rectified oil by weight.
The molecule is highly volatile and lipophilic, so after oral or inhaled dosing it partitions readily into lipid membranes and is detectable in expired air, which is the basis of its characteristic aroma on the breath.
Crude eucalyptus leaf oil also contains alpha-pinene, limonene and small amounts of aldehydes and phenols; rectification by fractional redistillation raises the cineole proportion and removes the more irritant minor constituents.
1,8-cineole is a TRPM8 agonist, the same cold-sensing channel menthol activates, which accounts for the cooling sensation reported in the nose and throat without any change in actual tissue temperature.
Where Eucalyptus (1,8-Cineole) comes from.
Steam is pushed through eucalyptus leaves, which carries the aromatic oil out with it. The oil is condensed, separated from the water, then redistilled to concentrate the main compound and remove the harsher minor ones. A lab test confirms how much of that main compound is in the finished oil.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Fresh or partly wilted leaf and terminal branchlets, harvested from plantations chiefly in China, Portugal, Spain, Brazil and Australia; cineole content varies by species, chemotype and season.
Steam passed through packed leaf material carries the volatile oil over with it; the condensate separates into an oil layer and an aqueous hydrosol layer.
The crude oil is redistilled under controlled conditions to raise the 1,8-cineole fraction and remove lower-boiling constituents and aldehydes that carry more irritant potential.
Gas chromatography establishes the 1,8-cineole percentage against the pharmacopoeial specification, and the oil is blended between batches where necessary to hit the declared figure.
Rectified oil is filled into softgels, coated where gastro-resistant release is intended, or diluted into a carrier base for external preparations.
Getting Eucalyptus (1,8-Cineole) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Reviews essential oils studied in sports recovery and performance contexts, eucalyptus among them, and notes that most supporting work is small or preclinical.Narrative review. Ivanova et al., 2025 (Molecules). PMID 41011665 ↗
- Examined the antimicrobial activity of natural essential oils against multidrug-resistant food-borne organisms, describing membrane disruption as the leading mechanism; laboratory only.In vitro study. Gharbi et al., 2026 (Foods). PMID 41596906 ↗
- Eucalyptus globulus oil supplementation was associated with changes in growth performance and serum biochemical measures in a livestock feeding study; non-human and not translatable to human dosing.Animal study. Ji et al., 2026 (Frontiers in Veterinary Science). PMID 41924726 ↗
- Reports that eucalyptus globulus essential oil altered physiological measures under cold stress conditions in broiler chickens; an animal husbandry finding with no human counterpart.Animal study. Mohebodini et al., 2025 (Poultry Science). PMID 40915087 ↗
- A microencapsulated essential oil blend, eucalyptus among the components, was associated with changes in productive parameters, antioxidant status and meat quality; the blend design means no single oil can be credited.Animal study. Safari et al., 2026 (Poultry Science). PMID 42184639 ↗
These are the studies our verdict leans on, chosen from the 5 we read for Eucalyptus (1,8-Cineole). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.